In accordance with section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92-463), the Centers for Disease Control and Prevention (CDC) announces the following meeting:
Name: Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Human Immunodeficiency Virus Prevention Projects for Community-Based Organizations, Program Announcement Number 04064.
Times and Dates: 1 p.m.-4 p.m., February 22, 2004 (Open); 9 a.m.-5 p.m., February 23, 2004 (Closed); 9 a.m.-5 p.m., February 24, 2004 (Closed); 9 a.m.-5 p.m., February 25, 2004 (Closed); 9 a.m.-5 p.m., February 26, 2004 (Closed); 9 a.m.-5 p.m., February 27, 2004 (Closed); 9 a.m.-12 p.m., February 28, 2004 (Closed).
Place: The Westin Atlanta North at Perimeter Center, 7 Concourse Parkway, Atlanta, GA 30328, Telephone (770) 395-3900.
Status: Portions of the meeting will be closed to the public in accordance with provisions set forth in Section 552b(c) (4) and (6), Title 5 U.S.C., and the Determination of the Director, Management Analysis and Services Office, CDC, pursuant to Public Law 92-463.
Matters To Be Discussed: The meeting will include the review, discussion, and evaluation of applications received in response to Program Announcement Number 04064.
For Further Information Contact: Beth Wolfe, Resource Funding Analyst, National Center for HIV, STD, and TB Prevention, CDC, 1600 Clifton Road, NE., MS-E07, Atlanta, GA 30333, Telephone (404) 639-8531.
The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both CDC and the Agency for Toxic Substances and Disease Registry.
Dated: January 30, 2004.
Alvin Hall,
Director, Management Analysis and Services Office, Centers for Disease Control and Prevention.
[FR Doc. 04-2397 Filed 2-4-04; 8:45 am]
BILLING CODE 4163-18-P